MONOPAR THERAPEUTICS INC's ticker is MNPR and the CUSIP is 61023L108. A total of 12 filers reported holding MONOPAR THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $54,301 | -36.0% | 87,596 | -11.7% | 0.00% | – |
Q2 2023 | $84,796 | -39.0% | 99,176 | -0.8% | 0.00% | – |
Q1 2023 | $138,977 | -41.3% | 99,976 | 0.0% | 0.00% | – |
Q4 2022 | $236,943 | +55.9% | 99,976 | +0.1% | 0.00% | – |
Q3 2022 | $152,000 | -33.9% | 99,879 | 0.0% | 0.00% | – |
Q2 2022 | $230,000 | -9.8% | 99,879 | 0.0% | 0.00% | – |
Q1 2022 | $255,000 | -20.6% | 99,879 | 0.0% | 0.00% | – |
Q4 2021 | $321,000 | -34.1% | 99,879 | 0.0% | 0.00% | – |
Q3 2021 | $487,000 | -15.2% | 99,879 | +2.5% | 0.00% | – |
Q2 2021 | $574,000 | +105.7% | 97,462 | +116.2% | 0.00% | – |
Q1 2021 | $279,000 | – | 45,070 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
American Portfolios Advisors | 700 | $1,610 | 0.00% |
ROYAL BANK OF CANADA | 4,116 | $9,000 | 0.00% |
VANGUARD GROUP INC | 99,879 | $230,000 | 0.00% |
UBS Group AG | 19,561 | $45,000 | 0.00% |
IFP Advisors, Inc | 500 | $13,000 | 0.00% |
FMR LLC | 10 | $0 | 0.00% |
WELLS FARGO & COMPANY/MN | 29 | $0 | 0.00% |
NORTHERN TRUST CORP | 35,203 | $81,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 39,171 | $85,000 | 0.00% |